Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Advanced glycation end products: role in pathology of diabetic cardiomyopathy.

Bodiga VL, Eda SR, Bodiga S.

Heart Fail Rev. 2014 Jan;19(1):49-63. doi: 10.1007/s10741-013-9374-y. Review.

PMID:
23404649
2.

AGE, RAGE, and ROS in diabetic nephropathy.

Tan AL, Forbes JM, Cooper ME.

Semin Nephrol. 2007 Mar;27(2):130-43. Review.

PMID:
17418682
3.

Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.

Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S.

Curr Pharm Des. 2008;14(10):962-8. Review.

PMID:
18473846
4.

Role of advanced glycation end products in diabetic neuropathy.

Sugimoto K, Yasujima M, Yagihashi S.

Curr Pharm Des. 2008;14(10):953-61. Review.

PMID:
18473845
5.

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.

Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ.

Eur J Heart Fail. 2007 Dec;9(12):1146-55. Review.

6.

Role of advanced glycation end products and their receptors in development of diabetic neuropathy.

Wada R, Yagihashi S.

Ann N Y Acad Sci. 2005 Jun;1043:598-604. Review.

PMID:
16037282
7.

Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.

Yamagishi S.

Ther Apher Dial. 2009 Dec;13(6):534-9. doi: 10.1111/j.1744-9987.2009.00775.x. Review.

PMID:
19954478
8.

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Falcão-Pires I, Leite-Moreira AF.

Heart Fail Rev. 2012 May;17(3):325-44. doi: 10.1007/s10741-011-9257-z. Review.

PMID:
21626163
9.

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.

Yamagishi S.

Exp Gerontol. 2011 Apr;46(4):217-24. doi: 10.1016/j.exger.2010.11.007. Epub 2010 Nov 25. Review.

PMID:
21111800
10.
11.

Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Rajesh M, Bátkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horváth B, Holovac E, Cinar R, Liaudet L, Mackie K, Haskó G, Pacher P.

Diabetes. 2012 Mar;61(3):716-27. doi: 10.2337/db11-0477. Epub 2012 Feb 7.

12.

Advanced glycation end products and diabetic nephropathy.

Thomas MC, Forbes JM, Cooper ME.

Am J Ther. 2005 Nov-Dec;12(6):562-72. Review.

PMID:
16280650
13.

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.

Cooper ME.

Am J Hypertens. 2004 Dec;17(12 Pt 2):31S-38S. Review.

PMID:
15607433
14.
15.

Advanced glycation end products in diabetic cardiomyopathy: an alternative hypothesis.

Hofmann Bowman MA, Fedson S, Schmidt AM.

J Heart Lung Transplant. 2011 Nov;30(11):1303; discussion 1303-4. doi: 10.1016/j.healun.2011.06.004. Epub 2011 Jul 2. No abstract available.

16.

Advanced glycation end products and diabetic foot disease.

Huijberts MS, Schaper NC, Schalkwijk CG.

Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S19-24. doi: 10.1002/dmrr.861. Review.

PMID:
18442180
17.

Oxidative stress and advanced glycation in diabetic nephropathy.

Coughlan MT, Mibus AL, Forbes JM.

Ann N Y Acad Sci. 2008 Apr;1126:190-3. doi: 10.1196/annals.1433.018.

PMID:
18448815
18.

Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast.

Yamazaki KG, Gonzalez E, Zambon AC.

J Cardiovasc Transl Res. 2012 Dec;5(6):805-13. doi: 10.1007/s12265-012-9405-4. Epub 2012 Sep 29. Review.

PMID:
23054657
19.

The role of AGEs in cardiovascular disease.

Jandeleit-Dahm K, Cooper ME.

Curr Pharm Des. 2008;14(10):979-86. Review.

PMID:
18473849
20.

The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.

Hori O, Yan SD, Ogawa S, Kuwabara K, Matsumoto M, Stern D, Schmidt AM.

Nephrol Dial Transplant. 1996;11 Suppl 5:13-6. Review.

PMID:
9044300

Supplemental Content

Support Center